Literature DB >> 27497248

RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.

Ye Kong1, Shuiyan Zou1, Fenghua Yang1, Xia Xu1, Wenhong Bu2, Jihui Jia3, Zhifang Liu4.   

Abstract

RUNX3 is a transcriptional factor that has been shown to regulate protein-coding gene expression at the transcriptional level. However, the regulation of RUNX3 on miRNAs is not fully understood. In this study, we used miRNA microarray to identify the miRNAs that are regulated by RUNX3 and found that miR-29b showed the most up-regulation in RUNX3 over-expressed cells compared with the control cells. We used qRT-PCR to confirm the miRNA microarray results in several gastric cancer cells and found that RUNX3 could bind to the miR-29b promoter directly and cooperate with Smad3 to increase the promoter activity of miR-29b. In the clinical setting, both RUNX3 and miR-29b are down-regulated significantly in human gastric cancer tissues. A positive correlation between miR-29b and RUNX3 was found in the gastric cancer tissues. Additionally, we found that miR-29b suppressed the proliferation and metastasis of gastric cancer cells by directly targeting KDM2A. The miR-29b/KDM2A axis was involved in the RUNX3-mediated inhibition of gastric cancer cell proliferation and metastasis. Taken together, our results suggested that RUNX3-mediated up-regulation of miR-29b inhibited the proliferation and migration of gastric cancer cells by targeting KDM2A, representing a novel molecular mechanism for the tumor suppression action of RUNX3.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Gastric cancer; KDM2A; RUNX3; Smad3; miR-29b

Mesh:

Substances:

Year:  2016        PMID: 27497248     DOI: 10.1016/j.canlet.2016.07.038

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

2.  [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].

Authors:  Kun Cao; Liangquan Sun; Yewei Zhang; Tengfei Wang; Haiyang Li; Shi Zuo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

Review 3.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 4.  Histone demethylase KDM2A: Biological functions and clinical values (Review).

Authors:  Lisheng Liu; Jiangnan Liu; Qinghai Lin
Journal:  Exp Ther Med       Date:  2021-05-04       Impact factor: 2.447

5.  Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway.

Authors:  Lei Wang; Bojuan Lang; Youdong Zhou; Jinyang Ma; Keqi Hu
Journal:  Cell Cycle       Date:  2021-08-23       Impact factor: 5.173

Review 6.  MicroRNAs are involved in the development and progression of gastric cancer.

Authors:  Xiaolin Liu; Ruixia Ma; Bin Yi; Adam I Riker; Yaguang Xi
Journal:  Acta Pharmacol Sin       Date:  2020-10-09       Impact factor: 7.169

Review 7.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

8.  Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1.

Authors:  Hui Li; Guoqing Liu; Ke Pan; Xiongying Miao; Yong Xie
Journal:  Oncotarget       Date:  2017-09-30

9.  Knockdown of KDM2A inhibits proliferation associated with TGF-β expression in HEK293T cell.

Authors:  Wen-Hao Xu; Da-Yan Liang; Qi Wang; Jinhua Shen; Qing-Hua Liu; Yong-Bo Peng
Journal:  Mol Cell Biochem       Date:  2019-01-02       Impact factor: 3.396

Review 10.  Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers.

Authors:  Gaya Punnia-Moorthy; Peter Hersey; Abdullah Al Emran; Jessamy Tiffen
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.